Latest Videos |view all videos
Naser M. Ammash, M.D., references RESPECT trial outcomes and reviews current recommendations for the evaluation of patients who have had a transient ischemic attack or ischemic stroke prior to consideration for closure of a patent foramen ovale.
Mayo Clinic cardiologists, Stephen L. Kopecky, M.D., and Robert P. Frantz, M.D., discuss the link between diet and cardiovascular health.
Mayo Clinic cardiologists, Robert P. Frantz, M.D., and Gurpreet S. Sandhu, M.D., Ph.D., discuss chronic thromboembolic pulmonary hypertension and possible treatment options.
Mayo Clinic adult congenital heart disease expert, Naser M. Ammash, M.D., discusses partial anomalous pulmonary venous connection (PAPVC).
Mayo Clinic interventional cardiologist, David R. Holmes Jr., M.D., and cardiac surgeon, Lyle Joyce, M.D., discuss percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG) in the post-SYNTAX era.
Mayo Clinic cardiologists, Naser M. Ammash, M.D., and Christopher J. McLeod, M.B., Ch.B., Ph.D., discuss how to assess stroke risk in people with adult congenital heart disease (ACHD).
Mayo Clinic electrophysiologist, Paul A. Friedman, M.D., reviews when premature ventricular complexes (PVCs) require further evaluation, the type of evaluation required and when treatment is necessary.
Steve R. Ommen, M.D., director, Hypertrophic Cardiomyopathy Clinic at Mayo Clinic, discusses management of symptoms in people with hypertrophic cardiomyopathy, as well as assessment of risk of sudden cardiac death.
Steve R. Ommen, M.D., director, Hypertrophic Cardiomyopathy Clinic at Mayo Clinic, reviews risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy.